274P Impact of dose reductions on efficacy of adjuvant abemaciclib for patients with high-risk early breast cancer (EBC): Analyses from the monarchE study
作者
Joyce O’Shaughnessy,I. Cicin,Laura Testa,Sara M. Tolaney,Jens Huober,Valentina Guarneri,Stephen R.D. Johnston,M. Martín Jiménez,Priya Rastogi,Nadia Harbeck,Hope S. Rugo,Ran Wei,V. Andre,Ashwin Shahir,Matthew Philip Goetz